Return
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants
DOI:10.1016/j.xcrm.2025.102210.png)
Abstract
En 中文
• CD38hiCD8+ T cells are associated with ICB resistance in melanoma • CD38 expression is induced by chronic TCR stimulation and type I IFN signaling • Blocking CD38 restores NAD+ pools and mitochondrial function • Dual PD-1/CD38 blockade overcomes ICB resistance in patient-derived 3D tumor models
Keywords:
CD38
PD-1
immunotherapy
T cell exhaustion
organotypic tumor spheroids
ex vivo
3D microfluidic culture
cytokines
NAD+
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
10.6
Papers:
2.2K
Citations:
8.9K

